中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
25期
77-79
,共3页
王宝锋%曾宪强%孟春香%刘冬
王寶鋒%曾憲彊%孟春香%劉鼕
왕보봉%증헌강%맹춘향%류동
急性肾损伤%肝细胞癌%经动脉栓塞化疗术%危险因素
急性腎損傷%肝細胞癌%經動脈栓塞化療術%危險因素
급성신손상%간세포암%경동맥전새화료술%위험인소
Acute kidney injury%Hepatocellular carcinoma%Transarterial chemoembolization%Risk factors
目的:探讨肝细胞癌经导管动脉栓塞化疗术后急性肾损伤的相关危险因素。方法回顾性研究该院2010年1月-2015年1月接受动脉栓塞化疗术的318例患者的临床资料,以发生急性肾损伤为观察终点,将患者分为急性肾损伤组和非肾损伤组,对急性肾损伤发生相关的危险因素进行分析。结果318例入组患者中,发生TACE后AKI共29例,发生率为9.1%。多因素Logistic回归分析结果显示,表明年龄>55岁(OR=3.34,95%CI:1.21~9.79)、谷草转氨酶>55 U/L(OR=4.53,95%CI:1.78~10.91)、糖尿病(OR=5.12,95%CI:1.58~11.90)是经动脉栓塞化疗术后急性肾损伤发生的独立危险因素。结论老年(年龄>55岁)、谷草转氨酶>55 U/L、糖尿病是经动脉栓塞化疗后急性肾损伤发生的独立危险因素。
目的:探討肝細胞癌經導管動脈栓塞化療術後急性腎損傷的相關危險因素。方法迴顧性研究該院2010年1月-2015年1月接受動脈栓塞化療術的318例患者的臨床資料,以髮生急性腎損傷為觀察終點,將患者分為急性腎損傷組和非腎損傷組,對急性腎損傷髮生相關的危險因素進行分析。結果318例入組患者中,髮生TACE後AKI共29例,髮生率為9.1%。多因素Logistic迴歸分析結果顯示,錶明年齡>55歲(OR=3.34,95%CI:1.21~9.79)、穀草轉氨酶>55 U/L(OR=4.53,95%CI:1.78~10.91)、糖尿病(OR=5.12,95%CI:1.58~11.90)是經動脈栓塞化療術後急性腎損傷髮生的獨立危險因素。結論老年(年齡>55歲)、穀草轉氨酶>55 U/L、糖尿病是經動脈栓塞化療後急性腎損傷髮生的獨立危險因素。
목적:탐토간세포암경도관동맥전새화료술후급성신손상적상관위험인소。방법회고성연구해원2010년1월-2015년1월접수동맥전새화료술적318례환자적림상자료,이발생급성신손상위관찰종점,장환자분위급성신손상조화비신손상조,대급성신손상발생상관적위험인소진행분석。결과318례입조환자중,발생TACE후AKI공29례,발생솔위9.1%。다인소Logistic회귀분석결과현시,표명년령>55세(OR=3.34,95%CI:1.21~9.79)、곡초전안매>55 U/L(OR=4.53,95%CI:1.78~10.91)、당뇨병(OR=5.12,95%CI:1.58~11.90)시경동맥전새화료술후급성신손상발생적독립위험인소。결론노년(년령>55세)、곡초전안매>55 U/L、당뇨병시경동맥전새화료후급성신손상발생적독립위험인소。
Objective To investigate the risk factors of acute kidney injury (AKI) after transarterial chemoembolization (TACE) for hepatocellular carcinomas. Methods The clinical data of 318 patients undergoing TACE at our hospital from January 2010 to Jan-uary 2015 were examined retrospectively. The occurrence of AKI was used as primary endpoint. The patients were divided into the AKI group and the non-AKI group. The incidence and risk factors of AKI was examined. Results Of the enrolled 318 patients, 29 patients had AKI, and the incidence was 9.1%. The results of Logistic regression showed that age>55 years (OR=3.34, 95%CI:1.21-9.79), aspartate aminotransferase level>55U/L (OR=4.53, 95%CI:1.78-10.91)and diabetes (OR=5.12, 95%CI:1.58-11.90) were associated with the development of AKI after TACE procedure. Conclusion Old age (age>55 years), aspartate aminotrans-ferase level>55U/L and diabetes are the independent risk factors for post-TACE AKI development.